These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6128769)

  • 21. The effects of the specific uptake inhibitor Lu 10-171 (citalopram) upon brain indoleamine stores in the maturing mouse.
    Baker PC; Goodrich CA
    Gen Pharmacol; 1982; 13(1):59-61. PubMed ID: 6174394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of serotonin and noradrenaline uptake blockers on wakefulness and sleep in cats.
    Hilakivi I; Kovala T; Leppävuori A; Shvaloff A
    Pharmacol Toxicol; 1987 Mar; 60(3):161-6. PubMed ID: 3473457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Citalopram: a new potent inhibitor of serotonin (5-HT) uptake with central 5-HT-mimetic properties.
    Pawłowski L; Ruczyńska J; Górka Z
    Psychopharmacology (Berl); 1981; 74(2):161-5. PubMed ID: 6267647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of antidepressants on neuroendocrine axis in humans.
    Meltzer HY; Fang VS; Tricou BJ; Robertson A
    Adv Biochem Psychopharmacol; 1982; 32():303-16. PubMed ID: 6124090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a new series of bicyclic compounds with potential thymoleptic properties on the reserpine-resistant uptake mechanism of central and peripheral monoamine neurones in vivo and in vitro.
    Carlsson A; Fuxe K; Hamberger B; Malmfors T
    Br J Pharmacol; 1969 May; 36(1):18-28. PubMed ID: 5768100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents.
    Bonaventure P; Kelly L; Aluisio L; Shelton J; Lord B; Galici R; Miller K; Atack J; Lovenberg TW; Dugovic C
    J Pharmacol Exp Ther; 2007 May; 321(2):690-8. PubMed ID: 17314195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacology in vivo of the phenylindan derivative, Lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brain.
    Arnt J; Christensen AV; Hyttel J
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):101-7. PubMed ID: 2409454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin 5-HT
    Perez-Palomar B; Mollinedo-Gajate I; Berrocoso E; Meana JJ; Ortega JE
    Neuropharmacology; 2018 May; 133():491-502. PubMed ID: 29477299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of supidimide on brain neurotransmitter systems of rats and mice.
    Hennies HH; Günzler WA; Flohé L
    Arzneimittelforschung; 1984; 34(11):1471-80. PubMed ID: 6084511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction between tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors and the presynaptic 5-hydroxytryptamine inhibitory autoreceptors in the rat hypothalamus.
    Galzin AM; Moret C; Verzier B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):200-11. PubMed ID: 2864432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subarachnoidal administration of the 5-HT uptake inhibitor citalopram points to the spinal role of 5-HT in morphine antinociception.
    Larsen JJ; Christensen AV
    Pain; 1982; 14(4):339-345. PubMed ID: 6962420
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of citalopram, a specific serotonin uptake inhibitor, in tardive dyskinesia and parkinsonism.
    Korsgaard S; Noring U; Povlsen UJ; Gerlach J
    Clin Neuropharmacol; 1986; 9(1):52-7. PubMed ID: 3470139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain.
    Wong DT; Threlkeld PG; Best KL; Bymaster FP
    J Pharmacol Exp Ther; 1982 Jul; 222(1):61-5. PubMed ID: 6123593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Citalopram antagonizes the stimulation by lysergic acid diethylamide of presynaptic inhibitory serotonin autoreceptors in the rat hypothalamus.
    Langer SZ; Moret C
    J Pharmacol Exp Ther; 1982 Jul; 222(1):220-6. PubMed ID: 6953233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of antidepressants on uptake and receptor systems in the brain.
    Fuller RW; Wong DT
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):485-90. PubMed ID: 2868490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initial, clinical trial of a new, specific 5-HT reuptake inhibitor, citalopram (Lu 10-171).
    Gottlieb P; Wandall T; Overø KF
    Acta Psychiatr Scand; 1980 Sep; 62(3):236-44. PubMed ID: 6935914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The recovery of maturing brain from acute citalopram exposure.
    Baker PC; Hoff KM
    Gen Pharmacol; 1987; 18(1):35-6. PubMed ID: 2435605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-HT uptake inhibitors: psychopharmacological and neurobiochemical criteria of selectivity.
    Maître L; Baumann PA; Jackel J; Waldmeier PC
    Adv Biochem Psychopharmacol; 1982; 34():229-46. PubMed ID: 6215834
    [No Abstract]   [Full Text] [Related]  

  • 39. Neurochemical properties of 3,3-dimethyl-1-[3-(methylamino) propyl]-1-phenylindan HCl (LU 3-049) and selected tricyclic antidepressants.
    Salama AI; Goldberg ME
    Arch Int Pharmacodyn Ther; 1977 Feb; 225(2):317-29. PubMed ID: 849078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of antidepressant drugs, selective noradrenaline-or 5-hydroxytryptamine uptake inhibitors, on apomorphine-induced hypothermia in mice.
    Pawłowski L; Mazela H
    Psychopharmacology (Berl); 1986; 88(2):240-6. PubMed ID: 3006113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.